Angiotensin-II-Type-1-Receptor-Blockers, page 11

Search results for Angiotensin-II-Type-1-Receptor-Blockers

Found 1400 articles. Showing from 101 to 110.

Histology and histopathology (2008-08-20)
Allopurinol attenuates L-NAME induced cardiomyopathy comparable to blockade of angiotensin receptor.

Clinical nephrology (2008-11-12)
Additional renoprotective effects of azelnidipine combined with angiotensin receptor blockers in patients with diabetic nephropathy.

Expert opinion on therapeutic targets (2006-03-21)
Targeting angiotensin II type I receptors to reduce the risk of stroke in patients with hypertension.

Journal of hypertension (2009-07-09)
Effects of angiotensin II receptor blockers on diabetic nephropathy.

Hypertension (2005-01-28)
Angiotensin II type-1 receptor antagonism attenuates the inflammatory and thrombogenic responses to hypercholesterolemia in venules.

Nihon rinsho. Japanese journal of clinical medicine (2012-09-27)
[Alzheimer disease--contribution of renin-angiotensin system to Alzheimer disease progression].

Arteriosclerosis, thrombosis, and vascular biology (2002-07-15)
Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction.

Journal of hypertension (2006-08-17)
Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation.

Journal of atherosclerosis and thrombosis (2008-07-08)
Effect of the angiotensin II receptor antagonist telmisartan on lipoprotein lipase mass in preheparin serum.

Hypertension (2005-08-26)
Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.

Filters

Journals

Categories

Subjects

Year of publication

Español | English

© Galenicom 1999-2013